A weight-management service is more than the appointment where a prescription is considered. Patients also need to know who supplies the medicine, how they receive it, what happens between visits and which charges continue. Texas Weight Loss provides a reasonably concrete picture of the beginning of that journey: a clinic consultation, laboratory testing, body-composition analysis and an individualized plan. The public documentation becomes less specific when the prescription moves toward the pharmacy and, potentially, the patient’s home.
This review examines that care pathway using public documentation consulted October 19, 2026. Texas Weight Loss advertises six Texas locations, injectable semaglutide and tirzepatide, oral phentermine and nutritional support. It also publishes separate visit and semaglutide prices. Those details make it possible to prepare useful questions, but not to verify a complete treatment package. The central distinction is between the services the clinic describes directly and the dispensing, delivery and financial arrangements that still require confirmation.
At a glance
- Clinic footprint
- The provider advertises six Texas locations, with clinics in Austin, San Antonio and the Houston area.
- Initial evaluation
- The $150 initial visit lists a medical consultation, CMP, TSH, lipid panel, HbA1c and body-composition analysis; medication costs extra.Sources: [9]
- Ongoing appointments
- Monthly follow-up visits are advertised at $110, including consultation, an appetite-suppressant prescription if medically indicated and four energy-boosting shots.Sources: [9]
- Semaglutide charge
- Semaglutide is listed at $100–275 for a monthly supply depending on dosage; the listing does not establish an all-inclusive treatment price.Sources: [9]
A clinic-centered service, with a narrower telemedicine promise
Texas Weight Loss presents itself as a medical weight-management business with 20 years of experience and six locations across Texas. Its FAQ identifies Austin, San Antonio and several Houston-area locations. These are provider statements, not independently verified measures of experience or facility availability. For someone considering care, the practical starting point is therefore a particular clinic, rather than an assumption that every advertised service is available through a uniform statewide online program.
The website presents Joseph Sleiman with the credentials MD and FAAFP. That identifies a named medical professional in the provider’s materials, but does not establish who would conduct an individual appointment or independently verify credentials. Prospective patients should ask which clinician will evaluate them, who handles prescription decisions and whether the same person manages subsequent visits. Those responsibilities matter more to continuity than the presence of a clinician’s name on the website.
An after-hours telemedicine announcement says that service is exclusively for Texas residents. It does not establish the geographic policy for every offering, nor explain its platform, exact hours, charges or response times. Public Spanish-language materials are also available, but do not confirm Spanish-speaking appointments or support across all channels. Ask the selected clinic how to book, how to reach the treating team and which contact route applies after hours.
What happens before a prescription is considered
The documented entry point is a consultation at one of the clinics. Texas Weight Loss says that appointment covers the patient’s goals, medical history and a personalized plan. Its GLP-1 page describes evaluations to determine whether these medications may be appropriate, rather than promising a prescription to everyone who schedules. That distinction is important: paying for the initial evaluation buys an assessment and its listed services, not a guaranteed medication decision.
The first-visit description includes blood testing for liver, kidney and thyroid function, a medical consultation and body-composition analysis. The pricing page gives a more specific laboratory list: CMP, TSH, lipid panel and HbA1c. The FAQ also says an EKG is required for people with risk factors such as hypertension, diabetes or high cholesterol, and for those age 50 or older. The documentation does not establish whether an additional EKG charge applies.
Full GLP-1 eligibility criteria, a minimum age and a clinical-review turnaround are not established in the consulted materials. Bring questions about required records, testing arrangements and when results will be discussed. Our guide to preparing for a first consultation offers a framework for that conversation. NIDDK also advises discussing medicines, supplements, allergies and pregnancy plans with the treating clinician; a review cannot determine individual eligibility.
The treatment menu is broader than GLP-1 injections
Texas Weight Loss advertises injectable semaglutide and tirzepatide, alongside pills, supplements and other injections. Its Spanish-language semaglutide page describes subcutaneous administration and a semaglutide formulation with glycine. The documentation does not establish that every semaglutide offering contains glycine, identify a manufacturer or connect the published monthly price conclusively to that formulation. Patients should obtain the exact prescribed product description rather than treating the ingredient name as a complete specification.
Phentermine is described as an oral medication the practice commonly prescribes. The FAQ states a provider-specific criterion of a BMI of at least 30 and no comorbid condition; that statement should not be transferred to GLP-1 eligibility. A separate phentermine article says people with certain conditions, including heart disease, uncontrolled high blood pressure or a history of substance misuse, may not be candidates. These are the provider’s descriptions, not individualized treatment advice.
Other advertised options include vitamin B-6 and NAD+ injections, supplements and in-house intramuscular wellness injections such as B12, glutathione, Lipoden and amino-acid blends. Their availability does not establish that they are necessary components of GLP-1 care or that their benefits have been demonstrated here. The FAQ expressly says patients can decline injections. Ask which proposed services are optional, which are part of the visit package and what clinical purpose the prescriber assigns to each.
The pharmacy handoff needs a more specific explanation
A Spanish-language page says the practice offers access to in-house semaglutide sourced from a 503b compounding pharmacy. The pharmacy is not named in that passage. The provider presents this sourcing arrangement as supporting quality control and affordability, but those commercial claims do not independently verify the product. The documentation also leaves unresolved the exact formulation dispensed, the pharmacy’s location and how that sourcing statement relates to the separately advertised semaglutide-with-glycine therapy.
This is where product-specific language matters. FDA approval applies to a particular drug product, not to a clinic, pharmacy or ingredient name in general. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. That status alone does not prove clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.
Before accepting a prescription, request the dispensing pharmacy’s name, the exact formulation and presentation, and the appropriate contact for product questions. Also ask whether any medication will be dispensed at the clinic, collected elsewhere or shipped. Our pharmacy-handoff questions explain this division of responsibilities. The consulted documentation does not complete that handoff, so it cannot establish which party resolves a dispensing discrepancy, delayed supply or replacement request.
Home injections are documented; delivery arrangements are not
The FAQ says patients may administer injections at home after proper training by the medical team. That is a meaningful care-delivery detail: treatment need not consist entirely of injections given during clinic appointments. However, permission to self-administer does not explain how medicine reaches the patient, what equipment accompanies it or whether training is in person. Ask who provides instruction and whom to contact if the label, supplies or instructions are unclear.
The public documentation does not specify shipping, pickup, delivery charges, refrigeration procedures or expected arrival times. It also does not establish a timeline from consultation to prescription approval and dispensing. These are separate stages, not interchangeable promises. Someone planning around work, travel or an existing supply should obtain each expected interval directly, including what happens if testing or clinical review is incomplete. Nothing in the documented home-injection option establishes a mail-order service.
FDA advises patients not to use an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and to contact the provider or dispensing pharmacy. That advice is relevant if shipping is offered; it is not evidence of a Texas Weight Loss delivery problem. The guide to warm injectable deliveries explains the distinction. FDA also reports measuring and administration errors with compounded medication, reinforcing the importance of clear professional instructions rather than dose calculations from an article.
Published charges describe separate parts of care
The initial visit is advertised at $150, with consultation, the listed laboratory panel and body-composition analysis. Its package also lists four energy-boosting shots, a diet menu, meal plan and pantry-makeover guide. The page states that prescription eligibility is determined at the visit and medication is an additional charge. The $110 monthly follow-up lists consultation, an appetite-suppressant prescription if medically indicated and four energy-boosting shots; a prescription is not the same as included medication.
Semaglutide is separately listed at $100–275 for a monthly supply, depending on dosage. The listing does not specify an exact product presentation or establish that visits and other charges are included. Tirzepatide pricing is not established in the consulted documentation. These published amounts should not be hidden behind a blanket statement that pricing is unknown, but neither should they be combined into a purported universal package. The complete bill depends on details the public materials do not resolve.
Additional listings include energy-boosting shots at $20 each or $60 for four, and a separate body-composition analysis at $25. The provider’s “Fat Burner” shots are $25 each or $80 for four, with an asterisk linked to “Buy three get one free”; further promotional conditions are not stated in that block. Insurance acceptance, payment methods, prepayment, automatic renewal, cancellation, refunds and missed-appointment charges remain unestablished. Request written terms before paying.
| Service | Published charge | Important boundary |
|---|---|---|
| Initial weight-loss visit | $150 | Listed evaluation services and extras; medication is additional. |
| Monthly follow-up visit | $110 | Includes a prescription if indicated, not a promise of included medicine. |
| Semaglutide | $100–275 per monthly supply, depending on dosage | Exact presentation and inclusion of other fees are not established. |
| Energy-boosting shots | $20 each or $60 for four | Four are also listed within each advertised visit package. |
| “Fat Burner” shots | $25 each or $80 for four | Four-shot listing carries a “Buy three get one free” asterisk; further terms are unstated. |
Monthly monitoring is clearer than between-visit access
Texas Weight Loss asks patients to attend monthly follow-up appointments to track progress, explain results and adapt the plan. Its GLP-1 description says individualized care may include nutrition guidance, lifestyle recommendations, progress monitoring and medication management. The FAQ adds that meal plans reflect lifestyle and dietary preferences and include menus plus approved and unapproved food lists. These details describe an ongoing program rather than a prescription-only transaction, although actual visit content will require confirmation.
The Spanish-language semaglutide page says the team monitors treatment response and provides personalized help managing side effects. What remains unclear is the operational route for that help between appointments: a dedicated clinical number, messaging system, response window or separately charged consultation is not established. The after-hours telemedicine announcement does not fill those gaps. Ask whether the monthly fee covers interim clinical questions and who responds when the usual clinician is unavailable.
NIDDK describes follow-up as attention to tolerance and response, not merely renewed payment, and notes that treatment duration depends on response and side effects. That provides context for evaluating the clinic’s monthly model without assuming every patient follows the same course. Our guide to what ongoing support means can help structure questions about monitoring, continuity and escalation. A scheduled monthly visit and accessible help between visits are related but distinct services.
Resolve responsibility and conflicting messages before enrolling
The strongest practical preparation is a written explanation of who handles evaluation, prescribing, dispensing, injection instruction and follow-up. Texas Weight Loss documents several of those functions, but not the complete chain. The consulted materials also do not establish the operating legal entity or explain the relationship among Texas Weight Loss, Texas Weight Loss Now and the clinic45.com domain associated with its support email. These are clarification points, not evidence that care is unavailable or improperly delivered.
Safety messaging warrants a direct conversation as well. The FAQ minimizes significant side effects for B12 and Lipoden, while another injection page acknowledges possible B12 reactions, including allergic reactions. Neither message should be read as a guarantee of risk-free treatment. Likewise, the provider’s claims concerning glycine, muscle protection or rapid results are advertising claims, not clinical findings established by this review. Ask the clinician to separate the purpose of each proposed product from its promotional description.
Finally, obtain the financial and continuity terms alongside the clinical plan. Confirm which clinic will manage follow-up, whether testing can create additional charges, how medication supply is coordinated and what happens when an appointment is delayed. Ask separately about cancellation and refunds; one does not establish the other. The available documentation supports a real advertised GLP-1 service, but leaves enough unanswered that enrollment should follow a specific explanation of responsibilities rather than assumptions drawn from the menu.
Questions & answers
Can I start Texas Weight Loss entirely through telemedicine?
The documented starting process calls for a consultation at a clinic. A separate announcement advertises after-hours telemedicine exclusively for Texas residents, but does not establish a fully remote enrollment pathway. Ask the selected location whether the initial consultation, testing, training and follow-up must occur in person, and whether telemedicine has a separate charge.
Does the $150 initial visit include semaglutide?
The pricing page says medication is an additional charge and prescription eligibility is decided at the visit. Semaglutide is separately advertised at $100–275 for a monthly supply depending on dosage. The initial package lists consultation, specified laboratory tests, body-composition analysis, four energy-boosting shots and dietary materials. Obtain an itemized estimate rather than assuming the medication is included.
Which pharmacy supplies its semaglutide?
A Spanish-language page describes sourcing from a 503b compounding pharmacy, but does not name it. Another page advertises semaglutide with glycine. The consulted documentation does not establish whether all semaglutide uses that formulation or which presentation the published price covers. Request the pharmacy identity and exact prescription details before arranging the medication handoff.
Will I have to visit the clinic for every injection?
Not necessarily. The FAQ says patients may administer injections at home after training by the medical team, and may choose not to receive injections. That does not establish shipping or pickup arrangements. Ask how training works, how supplies are provided and whether monthly follow-up remains in person even when medication is administered at home.
What does the $110 monthly appointment cover?
The advertised monthly visit lists medical consultation, an appetite-suppressant medication prescription if medically indicated and four energy-boosting shots. It does not say medication itself is included. The FAQ describes monthly appointments for tracking progress, discussing results and adjusting the plan. Coverage of interim questions, additional testing or other services needs direct confirmation.
Are Spanish-language consultations and insurance billing available?
Public Spanish-language educational pages are available, but that does not confirm Spanish-speaking clinicians or support at every location. The consulted documentation also does not establish insurance acceptance, claim submission or medication authorization assistance. Confirm language access and billing separately with the chosen clinic; neither can be inferred from the availability of educational content or a published visit price.
Our assessment
Texas Weight Loss documents a more tangible beginning and follow-up structure than a bare prescription offer: clinic evaluation, named laboratory tests, body-composition analysis, nutritional materials, home-injection training and monthly appointments. Its published visit and semaglutide prices also give patients concrete figures to discuss. The weaker part of the documented pathway is the transition from prescription to supply. The pharmacy is unnamed, formulation details are incomplete, and delivery, interim support, insurance and cancellation terms remain unresolved. A useful next step is an itemized care plan identifying the treating clinician, dispensing pharmacy, exact medication, collection or shipping arrangements and recurring charges. The service merits consideration as an advertised Texas clinic-based option, but its public documentation is not a complete account of the care relationship or total cost.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Texas Weight Loss — faq ↗
- Texas Weight Loss — phentermine what to know for safe effective weight loss ↗
- Texas Weight Loss — es mx/weight loss supplements ↗
- Texas Weight Loss — official website ↗
- Texas Weight Loss — es mx/weight loss injections ↗
- Texas Weight Loss — glp 1 support ↗
- Texas Weight Loss — pricing ↗
- Texas Weight Loss — weight loss injections ↗
- Texas Weight Loss — es mx/how to inject your weight loss medication ↗
- Texas Weight Loss — how it works ↗